Status:
COMPLETED
An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care
Lead Sponsor:
Montefiore Medical Center
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Through this study, the investigators will adapt the ASTHMAXcel mobile app and evaluate the adapted intervention through a randomized controlled trial.
Detailed Description
Through this study, the investigators will use patient and provider feedback to adapt the ASTHMAXcel mobile intervention, and will conduct a randomized controlled trial to test the intervention's impa...
Eligibility Criteria
Inclusion
- English-speaking individuals \>18 years with:
- persistent asthma(diagnosis made by a healthcare provider) on a daily controller medication
- able to give informed consent
- Smartphone (iOS or Android) access
Exclusion
- use of oral corticosteroids in the 2 weeks prior to the baseline visit
- pregnancy
- severe psychiatric or cognitive problems that would prohibit an individual from completing the protocol
- patients that previously received ASTHMAXcel
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03847142
Start Date
March 1 2020
End Date
May 1 2023
Last Update
June 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467